Galway-based medtech SymPhysis Medical secures €1.5m in funding

Company looking to gain FDA approval for Releaze, a device that helps individuals cope with complication of late-stage cancers

Dr Michelle Tierney, co-founder and chief scientific officer, SymPhysis Medical, David Breen, consultant respiratory physician and lead clinician for lung cancer services, Galway University Hospital and Tim Jones, co-founder and chief executive